Post-transplant patients frequently develop new-onset diabetes after transplantation (NODAT) or experience worsening of pre-existing diabetes, largely due to immunosuppressive medications such as tacrolimus and corticosteroids
Comprehensive Phase 3 safety and efficacy data are required before a licensing decision can be considered
In vitro , Ma and colleagues [90] also showed liraglutide to reduce H 2 O 2 -related damage in RGCs through inhibition of mitophagy induction, primarily by reducing ROS and maintaining mitochondrial membrane potential
Schedule your GLP-1 check-in today and optimize your results from the inside out
adults are affected by obesity, while the World Health Organization estimates that 1 billion people globally are living with obesity, reinforcing strong demand for GLP-1 drugs as effective pharmacological solutions for weight management and metabolic health improvement
Retailers, then, face a double-edged sword when trying to figure out how GLP-1 drugs could impact their businesses